期刊文献+

慢性心衰患者血NT-proBNP、cTnT、hs-CRP检测的临床意义 被引量:17

Clinical significance of NT-proBNP,cTnT,hs-CRP mesurements in patients with chronic heart failure
暂未订购
导出
摘要 目的探讨慢性心衰患者NT-proBNP、cTnT、hs-CRP的检测和意义。方法测定慢性心衰患者(43例)和健康者(21例)NT-proBNP、cTnT和hs-CRP水平,并进行统计学分析。结果慢性心衰患者cTnT、hs-CRP、NT-proBNP血浆检测水平(中位值)分别为:2790.0ng/mL、0.041ng/mL、7.330mg/L。健康者分别为54.16ng/mL、0.003ng/mL、1.050mg/L。慢性心衰患者cTnT、hs-CRP、NT-proBNP水平均明显高于健康者(P<0.05)。慢性心衰患者NT-proBNP水平与cTnT水平、hs-CRP水平呈正相关(r=0.612,P<0.05;r=0.293,P<0.05)。心衰患者治疗后NT-proBNP、cTnT的水平低于治疗前(P<0.05);但治疗前后的hs-CRP水平差异没有统计学意义(P>0.05)。结论 NT-proBNP、cTnT、hs-CRP的联合检测有助于慢性心衰患者的诊断与疗效观察。 Objeetive To study the clincal significance of plasma levels of NT-proBNP. cTnT,hs-CRP in patients with chronic heart failure(CHF) and the possible pathophysiologie implications. Methods The plasma levels of NT-proBNP.cTnT.hs-CRP of 44 patients with CHF (CHF group) and 21 healthy people(control group) were tested. Results The levels of NT-proBNP,cTnT, hs-CRP(median value) in CHF group were 2 790.0 ng/mL, 0. 041 ng/mL, 7. 330 mg/L, respectively, and those of control group were 54.16 ng/mL.0. 003 ng/mL.1. 050 mg/L,respectively. CHF group and control group were statistically different in NT-proB- NP, eTnT, hs-CRP levels(P〈0.05). NT-proBNP were postively correlative with cTnT and hs-CRP level in CHF group(r= 0.612, 0. 293,P〈0.05). The levels of NT-proBNP and eTnT in patients with heart failure after treatment was significantly lower than that before treatment(P〈0.05), except for hs-CRP(P〉0.05). Conclusion The combined detection of NT-proBNP, cTnT,and Ths-CRP contribute to the diagnosis and curative for patients with CHF.
出处 《国际检验医学杂志》 CAS 2013年第15期1965-1966,1968,共3页 International Journal of Laboratory Medicine
关键词 心力衰竭 利钠肽 肌钙蛋白T C反应蛋白质 heart failure natriuretic peptide brain tropnin T C-reactive protein
  • 相关文献

参考文献8

二级参考文献44

共引文献40

同被引文献145

  • 1李守霞,赵素斌,杨建英,李廷贵.心力衰竭患者心肌肌钙蛋白T和超敏C反应蛋白的动态变化及预后价值[J].现代生物医学进展,2007,7(1):70-71. 被引量:9
  • 2郭永利,陈毅歆,黄德党,罗海峰,葛胜祥,程通,张军,夏宁邵.适于HIV-1 p24抗原检测试剂的单抗制备与筛选[J].中国人兽共患病学报,2007,23(6):527-531. 被引量:1
  • 3吴以岭主编.络病学基础与临床研究(5)[M].北京:军事医学科学出版社,2009:11.
  • 4中华医学会心血管病学分会,中华心血管病杂志编辑委员会.中国心力衰竭诊断和治疗指南2014[J].中华心血管病杂志,2014,42(1):98-122.
  • 5CHOI EY, BAHRAMI H, WU CO, et al. N-terminal pro-B-type natriuretic peptide, left ventricular mass, and incident heart failure: Multi-Ethnic Study of Atherosclerosis [ J ]. Circ Heart Fail,2012,5 (6) : 727 - 734.
  • 6BUCCI M,BORRA R, NAGREN K, et al. Trimetazidine reduces endogenous free fatty acid oxidation and improves myocardial efficiency in obese humans[J]. Cardiovasc Ther,2012,30(6) : 333 -341.
  • 7ZHOU X, LI C, XU W, et al. Trimetazidine protects against smoking-induced left ventricular remodeling via attenuating oxidative stress, apoptosis, and inflammation [ J ]. PLoS One, 2012,7(7) : e40424.
  • 8HU B, LI W, XU T, et al. Evaluation of trimetazidine in angina pectoris by echocardiography and radionuclide angiography: a meta-analysis of randomized, controlled trims [ J ]. Clin Cardiol, 2011,34(6) :395 -400.
  • 9GAO D, NING N, NIU X, et al. Trimetazidine : a meta-analysis of randomised controlled trims in heart failure [ J ]. Heart, 2011,97 (4) :278 -286.
  • 10Emdin M,Passino C,Prontera C, et al. Comparison of brain natriuretic peptide (BNP)and amino-terminal Pro BNP for early diagnosis of heart failure [J]. Clin Chem,2007,53 (7) : 1289-1297.

引证文献17

二级引证文献181

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部